Treatments, Simulants, and Screening

Learning Objectives

• Separate treatment, simulant identification, and natural/synthetic (laboratory-grown) screening as different questions.
• Require treatment disclosure to remain consistent across listing, report, invoice, and future service records.
• Apply screening only within validated scope and distinguish OUT-OF-RANGE device output from an OUT OF SCOPE applicability boundary.

Apply

Buyer’s Guide 08 — Treatments and Disclosure

Treatment can change the color, clarity, or appearance of a diamond. A buyer does not need to memorize every laboratory detail of every method, but must know that treatment status is not a minor footnote. It affects the product’s identity, care, service, documentation, and market comparison.

Red flags

• the seller uses words such as “enhanced” without a clear explanation;
• treatment is disclosed only after repeated questioning;
• the invoice omits a material disclosure that formed part of the sales discussion;
• “permanent” is used as though it meant “requires no special care”;
• a treated stone is price-compared with an untreated stone without disclosure;
• the workshop does not receive treatment information before working on the item.

Purchase checklist

• Treatment status is clear before payment.
• Listing, report, and invoice are consistent.
• I know whether special servicing or cleaning precautions apply.
• For color, I separate natural/synthetic origin from the color-origin/treatment question.
• I compare price with compatibly documented products.
• I keep treatment information with the item’s records for future service or resale.

Fracture filling and coating require particular caution because service/report eligibility and care can differ from an untreated stone. Do not generalize all treatment cases into one disclosure or service rule.

Buyer’s Guide 09 — Simulants, Screening, and Digital Fraud

A simulant, a synthetic diamond, and a treated natural diamond are not the same category of problem. A handheld tester that helps distinguish some materials may not be able to answer the origin or treatment question. A screening workflow therefore begins by classifying the task.

Red flags

• one home test is presented as final identification;
• “passes diamond tester” is used as proof of natural origin;
• the seller provides only a screenshot of report verification;
• the report number is real but the measurements do not match the stone or listing;
• the payment method removes reasonable return or dispute protection;
• the seller refuses independent verification in a high-value transaction.

Purchase checklist

• I know whether the question is simulant, origin, or treatment.
• I know the scope of the tester or screening device being used.
• I interpret device-result labels according to the validated workflow.
• I verify the official record independently.
• I connect the report to the physical stone.
• Seller identity and payment/delivery workflow are verifiable.
• For high risk, I have a plan for independent professional or laboratory verification.

For screening terminology, keep two concepts separate. OUT-OF-RANGE is a device-result label where defined by that device. OUT OF SCOPE describes a validation/applicability boundary and is not the same result. A REFER or OUT-OF-RANGE result follows the device’s defined escalation pathway; an OUT OF SCOPE case requires a method validated for that use case.

Check Your Understanding

• What is the exact treatment status, and is disclosure consistent across the transaction documents?
• Is there a care or workshop consequence that must be preserved with the stone’s records?
• What exact question can the tester or device answer?
• Am I keeping OUT-OF-RANGE separate from OUT OF SCOPE?
• Is the seller’s digital identity separate from report authenticity and physical-stone matching?
• What result or uncertainty would require laboratory escalation?

Sources

• Buyer’s Guide: 8. Treatments and Disclosure: What Must Be Clear Before You Buy
• Buyer’s Guide: 9. Simulants, Screening, and Digital Fraud
• Handbook: 20. Treatments: What Changes and What Must Be Disclosed
• Handbook: 21. Simulants and Practical Identification
• Handbook: 23. Screening, Devices, and Digital Fraud
• The Book: 57. Why Diamonds Are Treated
• The Book: 58. Laser Drilling
• The Book: 59. Fracture Filling
• The Book: 60. HPHT Treatment of Natural Diamonds
• The Book: 61. Irradiation and Annealing
• The Book: 62. Coatings and Surface Modifications
• The Book: 63. Combined and Emerging Treatments
• The Book: 64. Simulants: How to Structure the Problem
• The Book: 65. Moissanite, Cubic Zirconia, and Other Simulants
• The Book: 66. A Practical Identification Workflow
• The Book: 67. Handheld Testers and False Positives
• The Book: 73. Screening Devices and the ASSURE Program
• The Book: 74. Counterfeiting and Digital Fraud